U of MD Marlene and Stewart Greenebaum
Locations
Transplant Summary
Overview
The University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Transplant and Cellular Therapy Program, part of a NCI-designated Cancer Center, has been serving the Baltimore metropolitan area, Maryland and the mid-Atlantic states since 1993. We specialize in matched sibling, matched unrelated and haploidentical family member donor transplants for all types of hematologic malignancies and bone marrow failure syndromes in both adults and children. We also offer advanced research studies in the areas of immunotherapy, infection prevention and supportive care. We are also closely aligned with outstanding clinical programs in leukemia, lymphoma and myeloma to ensure cohesive and comprehensive care. In addition, we offer all the FDA approved cellular therapy drugs.This center has been performing allogeneic transplants since 1995 and has been an NMDP transplant center since November 1997.
Attending physicians
Adult - Djordje Atanackovic, Ashraf Badros, Ariel Fromowitz, Nancy Hardy, Mehmet Kocoglu, Aaron Rapoport, Jean YaredTransplants performed
Marrow/PBSC and single cordCord blood transplants
Adult onlyOther programs and services
We partner with the local American Cancer Society in the use of the Hope Lodge for housing.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 103 patients.The actual 1-year survival of these patients is 77.7%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.2% and 83.2%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
252
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow1PBSC33Cord blood0Total34Unrelated donorMarrow0PBSC36Cord blood0Total36Total allogeneicMarrow1PBSC69Cord blood0Total70AutologousMarrowBoth marrow & PBSC 182PBSC—Cord blood—Total182Total combinedMarrowBoth marrow & PBSC 252PBSC—Cord blood0Total252Total pediatric transplants
0
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC0Cord blood0Total0Unrelated donorMarrow0PBSC0Cord blood0Total0Total allogeneicMarrow0PBSC0Cord blood0Total0AutologousMarrowBoth marrow & PBSC 0PBSC—Cord blood—Total0Total combinedMarrowBoth marrow & PBSC 0PBSC—Cord blood0Total0All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44545-641965+10Total34Unrelated 0-18019-44645-641765+13Total36Autologous 0-18019-442545-6410565+52Total182Total 0-18019-443645-6414165+75Total252Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.